All publications

Original Article · 2023

Perioperative Hormone Management in Gender-Affirming Mastectomy: Is Stopping Testosterone before Top Surgery Really Necessary? Plast Reconstr Surg

Robinson IS, Rifkin WJ, Kloer C, Parker A, Blasdel G, Shakir N, Zhao LC, Bluebond-Langner R

2023 Feb 1;151(2):421-427 · 2023

PubMed DOI PMID 36374270

Citation

Robinson IS, Rifkin WJ, Kloer C, Parker A, Blasdel G, Shakir N, Zhao LC, Bluebond-Langner R. Perioperative Hormone Management in Gender-Affirming Mastectomy: Is Stopping Testosterone before Top Surgery Really Necessary? Plast Reconstr Surg. 2023 Feb 1;151(2):421-427. doi: 10.1097/PRS.0000000000009858. Epub 2022 Nov 15. PMID: 36374270.

Key Points

  • Published in 2023 Feb 1;151(2):421-427 in 2023.
  • Indexed in PubMed as PMID 36374270.
  • Mapped to Gender-Affirming Surgery.

Clinical Relevance

This publication supports a focused body of work on gender-affirming surgery, including patient-centered outcomes, robotic peritoneal flap vaginoplasty, complications, revisions, and measurement of surgical quality.

Related Publications